Alto Neuroscience, Inc. · NYSE:ANRO
Vestal Point Capital, LP's stake in Alto Neuroscience, Inc. fell to 2.20% (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 14, 2026
Vestal Point Capital, LP's stake in Alto Neuroscience, Inc. fell to 2.20%, 785,000 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).
- Stake
- 2.20%
- Shares
- 785,000
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Vestal Point Capital, LP | 2.20% | 785,000 |
| Ryan Wilder | 2.20% | 785,000 |
Source
Related
- Alto Neuroscience, Inc.
- Vestal Point Capital, LP
- Alto Neuroscience, Inc. shareholders
- Schedule 13G/A · Vestal Point Capital, LP · May 15, 2026
- Schedule 13G · Vestal Point Capital, LP · Feb 17, 2026
- Form 4 · Smith Nicholas Conrad · Oct 5, 2026
- Form 4 · Smith Nicholas Conrad · Oct 1, 2026
- Schedule 13G/A · Perceptive Advisors LLC · Aug 14, 2026
- Schedule 13G/A · Sirenia Capital Management LP · Aug 14, 2026
- Schedule 13G · BlackRock, Inc. · Jul 27, 2026